Latest Intelligence

Published within

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... | » »|

Type Product title / description Pub Price
NewsWire
NewsWire

Mercator MedSystems appoints CEO

Mercator MedSystems, Inc., a developer of catheter-guided micro-infusion systems, has appointed Trent Reutiman as CEO and member of the board.

Published By MarketLine
23 Apr 2014
NewsWire
NewsWire

Illumina reports net income for Q1, provides outlook for fiscal 2014

Illumina, Inc., a provider of life science tools and systems for analysis of genetic variation, has reported a net income of $59.98 million, or $0.40 per diluted share, for the first quarter ended March 30, 2014, compared to a net loss of $22.59 million, or $0.18 loss per diluted share, for the same quarter ended March 31, 2013. For fiscal 2014, the company expects non-GAAP earnings per fully diluted share to be in the range of $2.10 to $2.15.

Published By MarketLine
23 Apr 2014
NewsWire
NewsWire

Intuitive receives FDA clearance for da Vinci Sp Surgical System

Intuitive Surgical, Inc., a provider of robotic surgical systems, has received FDA 510(k) clearance for the da Vinci Sp Surgical System, which is designed to expand the company's single-incision product offering.

Published By MarketLine
23 Apr 2014
NewsWire
NewsWire

Salix and Progenics receive EMA acceptance for OIC drug review

Salix Pharmaceuticals, Ltd. and Progenics Pharmaceuticals, Inc. have received the European Medicines Agency, or EMA, acceptance for reviewing RELISTOR subcutaneous injection for the treatment of opioid-induced constipation, or OIC, in adult patients with chronic non-cancer pain.

Published By MarketLine
23 Apr 2014
NewsWire
NewsWire

Tetraphase receives FDA fast track designations for antibiotic candidate

Tetraphase Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, has received fast track designations from FDA for both the intravenous, or IV, and oral formulations of the company's lead antibiotic candidate, eravacycline.

Published By MarketLine
23 Apr 2014
NewsWire
NewsWire

Eagle Pharmaceuticals receives patent for treatment of heat stroke from USPTO

Eagle Pharmaceuticals, Inc., a specialty pharmaceutical company, has received a patent from US Patent and Trademark Office, or USPTO, for the treatment of heat stroke with the company's dantrolene sodium for injectable suspension.

Published By MarketLine
23 Apr 2014
NewsWire
NewsWire

Vyrix signs agreement with Paladin Labs for treatment for premature ejaculation

Vyrix Pharmaceuticals, a specialty pharmaceutical company, has signed an agreement with Paladin Labs Inc., a specialty pharmaceutical company, to provide exclusive rights to market, sell and distribute Zertane in Canada, the Republic of South Africa, Sub-Saharan Africa and Latin America.

Published By MarketLine
23 Apr 2014
NewsWire
NewsWire

Ampio announces encouraging results from osteoarthritis of knee study

Ampio Pharmaceuticals, Inc., a development-stage biopharmaceutical company, has announced the results of the 20 weeks extension of the Ampion SPRING study evaluating intra-articular injection of Ampion for the treatment of inflammation-associated pain in symptomatic osteoarthritis, or OA of the knee, or OAK.

Published By MarketLine
23 Apr 2014
NewsWire
NewsWire

Spiracur receives FDA clearance for wound care dressing with HBOT

Spiracur Inc., a developer of wound healing technologies, has received 510(k) clearance from FDA for the SNaP Wound Care Dressing with fittings and cartridge removed for use in a hyperbaric oxygen therapy, or HBOT, chamber for the treatment of chronic wounds.

Published By MarketLine
23 Apr 2014
NewsWire
NewsWire

CROMA-PHARMA signs distribution agreement with HUGEL for Botulinum toxins

CROMA-PHARMA GmbH, a specialty pharmaceutical and surgical company, has signed a 10-year distribution agreement with HUGEL Inc., a producer of Botulinum toxins and anti-aging products.

Published By MarketLine
23 Apr 2014

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... | » »|

No help is available.